Construction and Operation of a PCR Testing System in Kobe City
First written in FY2021-Q1. 2 of 4 entries say "Restated". Latest entry: FY2022-Q3.
No other company in this theme has enough history to compare yet.
- FY2022-Q3RestatedAnnual report
「May 2021: To expand testing capacity and enhance functionality, the company relocated to its R&D Center and began operating Japan's first public-private PCR testing laboratory for COVID-19, established in June 2020 in the Kobe Biomedical Innovation Cluster.」
The company has reiterated the relocation and launch of operations of the public-private PCR testing laboratory at its R&D Center, together with efforts to expand testing capacity and enhance functionality. - FY2022-Q2RestatedAnnual report
「May 2021: The company relocated to its R&D Center and began operating Japan's first public-private PCR testing laboratory for COVID-19, established in June 2020 in the Kobe Biomedical Innovation Cluster.」
The company has reiterated the relocation of the public-private PCR testing laboratory to its R&D Center and the start of operations. - FY2022-Q1AdvancedAnnual report
「May 2021: The company relocated to its R&D Center and began operating Japan's first public-private PCR testing laboratory for COVID-19, established in June 2020 in the Kobe Biomedical Innovation Cluster.」
The company relocated the public-private PCR testing laboratory established in the Kobe Biomedical Innovation Cluster to its R&D Center and began operating it in May 2021. - FY2021-Q1First statedAnnual report
「To prepare for the spread of COVID-19 and help strengthen the COVID-19 PCR testing framework in Kobe, Kobe City, the company and 株式会社エスアールエル, a subsidiary of みらかホールディングス株式会社 (now H.U. Group Holdings, Inc.), jointly established and began operating a new PCR testing framework at Sysmex BMA Laboratory, a public health laboratory in the Kobe Biomedical Innovation Cluster. Under this initiative, the company performs PCR testing, while 株式会社エスアールエル supports the establishment of the testing framework and handles sample collection, reporting of results and other functions. The company plans to strengthen its PCR testing capabilities as necessary.」
Kobe City, the company and 株式会社エスアールエル jointly established and began operating a PCR testing framework at a public health laboratory in the Kobe Biomedical Innovation Cluster. The division of responsibilities and plans to strengthen the framework as necessary were also set out.